Chelsea Sedlak

NP | Nurse Practitioner - Acute Care

Chelsea Sedlak is a Binghamton, New York based nurse practitioner who is specialized as Acute Care nurse. Her current practice location is 169 Riverside Dr, Binghamton. Patients can reach her at 607-798-5111. Chelsea Sedlak is NP with specialization in Acute Care and her NPI number (Unique professional ID assigned by NPPES) is 1326805029.
Chelsea Sedlak is a licensed independent practitioner and may autonomously provide care. She provides advanced nursing care across the continuum of health care services to meet the specialized physiologic and psychological needs of patients with acute, critical, and/or complex chronic health conditions. This care is continuous and comprehensive and may be provided in any setting where the patient may be found.

Complete Profile:
Chelsea Sedlak speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Chelsea Sedlak
Specialization: Acute Care Nurse Practitioner (ACNP)
Gender:Female
Credentials: NP
Practice Address:169 Riverside Dr, Binghamton,
New York, 13905-4246
Phone:607-798-5111
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1326805029
NPI Enumeration Date: 29 Feb, 2024
NPI Last Update On: 29 Feb, 2024

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Chelsea Sedlak
21 Rotary Ave,
Binghamton, New York
Zip: 13905-4109
Patients can reach Chelsea Sedlak at 169 Riverside Dr, Binghamton, New York or can call to book an appointment on 607-798-5111.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.